(Q94495531)

English

Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement

scientific article published on 28 April 2020

Statements

Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit